Position in ZVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,657,315
+$3,442,874 QoQ
Shares Held
882,658
-10.7% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#13
of 157 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $280,034,602 across 30 Biotechnology names. ZVRA ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
789,745 | $55,795,484 | |
| 2 | INVA |
Innoviva, Inc.
|
1,172,690 | $26,631,789 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
91,041 | $22,284,105 | |
| 4 | CRMD |
CorMedix Inc.
|
2,176,362 | $17,084,441 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
218,487 | $16,272,911 | |
| 6 | ALMS |
Alumis Inc.
|
525,303 | $14,782,026 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
362,464 | $13,197,314 | |
| 8 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
882,658 | $12,657,315 |
All Filings in ZVRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,657,315 | 882,658 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,214,441 | 988,674 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,757,765 | 865,822 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,573,682 | 691,239 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||